Cancer Care Politics and Treatments
November 26, 2016
Dr. Debra Patt, practicing oncologist and Vice President of Texas Oncology, explains how the well-intentioned federal 340B Drug Discount Program is actually driving up cancer care costs. With preferred vendor hospitals applying their 30-50% drug discounts to all patients, not just the underserved, industry-wide prices are being forced up to subsidize the program. On the whole, however, Patt is optimistic about the diagnostic innovations, therapeutic success, and a drastic drop in cancer mortality rates.
LISTEN (full–length interview)
DOWNLOAD from iTunes (as aired)
WATCH (on YouTube)
Bill Frezza 
Leave a Reply